This inventor holds 6 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Centre Leon Berard, Institut Jean Paoli & Irène Calmettes, National Institute of Health and Medical Research. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 39 
6 out of 32 
6 out of 1,853 
Years Active: 2016-2021
Title: The Innovations of Julien Faget
Introduction
Julien Faget is a prominent inventor based in Lyons, France, credited with six patents that reflect his significant contributions to medical research and immunology. His work focuses on the development of antibodies and their applications in treating various conditions through the modulation of immune responses.
Latest Patents
Faget's latest patents include groundbreaking inventions regarding antibodies directed against ICOS (Inducible T-cell Costimulator). These antibodies are designed to neutralize ICOS engagement on regulatory T cells (Treg) by inhibiting the interaction between ICOS and its ligand, ICOS-L. This innovative approach abrogates the proliferation of Treg induced by plasmacytoid dendritic cells. Moreover, these antibodies promote the production of cytokines such as IL-10 and IFN-γ, induce proliferation of CD4- T cells, reduce the proliferation of conventional T cells (Tconv), and enhance the immunosuppressive function of Treg. This patent has remarkable implications for immunotherapy and autoimmune disease treatment.
Career Highlights
Throughout his career, Julien Faget has collaborated with esteemed institutions, including the Institut National de la Santé et de la Recherche Médicale and the Institut Jean Paoli & Irene Calmettes. His dedication to advancing immunological research has led to important discoveries in how the immune system can be manipulated for therapeutic purposes.
Collaborations
Faget has worked alongside distinguished colleagues in the field, notably Christophe Caux and Christine Menetrier-Caux. These collaborations have fostered innovative research and development, pushing the boundaries of immunology and therapeutic interventions.
Conclusion
Julien Faget's inventive spirit and dedication to scientific research have resulted in significant advancements in the field of immunology. His patents not only contribute to the scientific community but also have the potential to transform the way we approach the treatment of immune-related diseases. With ongoing collaborations and a commitment to innovation, Faget remains a key figure in the landscape of modern medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile